Evaluation of the alcazar scoring system in differentiating benign from malignant ovarian tumors

Authors

  • Sahu Mahija Department of Obstetrics and Gynaecology, SCB Medical College & Hospital, Cuttack-753007, Odisha, India
  • Nathasha HK Department of Obstetrics and Gynaecology, SCB Medical College & Hospital, Cuttack-753007, Odisha, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20150415

Keywords:

Ovarian mass, Ultrasonography with color Doppler, Alcazar scoring system, Histopathology

Abstract

Background: To evaluate prospectively the diagnostic performance of Alcazar scoring system to differentiate Benign from Malignant ovarian tumors using gray scale ultrasonography and color Doppler.

Methods: The prospective cohort study was conducted from January 2014 to August 2014 in the department of Obstetrics and Gynecology, SCBMCH, Cuttack. The study includes 54 patients with ovarian tumors and all were subjected to ultrasound and color Doppler. The data obtained was used to score according to ALCAZAR system and the probability of malignancy was determined. The efficacy of the scoring system was evaluated by histopathological examination of the tumor and the ascitic fluid cytology as gold standard.

Results: Of the 54 cases, Alcazar scoring system identified 22 out of 25 malignant tumors and 27 out of 29 benign tumors. The sensitivity and specificity of the scoring system for diagnosing malignancy are 88% and 93.1% respectively. The positive predictive value and negative predictive value are 91% and 90% respectively.

Conclusions: Alcazar scoring system is more specific as a diagnostic tool to rule out malignancy and can be used to differentiate benign from malignant ovarian tumors. The main disadvantage being, it is operator dependent.

References

Alcazar JL, Mercee LT, Laparte C, Juardo M, Garcia L. A new scoring system to differentiate benign from malignant adnexal mass. Am J Obs Gyn. 2003;188:685-92.

Singh U, Kohli N, Nisha, Ekta. Evaluation of a new scoring system to differentiate between benign and malignant adnexal mass. The Journal of Obstetrics and Gynaecology of India. 2006;56(2):162-5.

Timor – Tritsch IE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of

colour flow directed Doppler measurements and a morphological scoring system. Am J Obs Gyn. 1993;168:909-13.

Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991;78:70–6.

DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, et al. Amorphology index based on sonographic findings in ovarian cancer. Gynecol Oncol. 1993;51:7–11.

Ferrazzi E, Zanetta G, Dordoni D, et al. Transvaginal ultrasonographic characterization of ovarian masses: A comparison of five scoring systems in a multicenter trial. Ultrasound Obstet Gynecol. 1997;10:192.

Ameye L, Valentine L, Testa AC, Van Holsbeke C, Domali E, Van Huffel S, et al. A scoring system to differentiate malignant from benign masses in specific ultrasound-based subgroups of adnexal tumors. 2009;33(1):92-101.

Brown DL, Doubilet PM, Miller FH, et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology. 1998;208:103-10.

Dhwani Desai, Desai VA, Verma RN, Shrivastava J. Role of gray scale and color Doppler in differentiating benign from malignant ovarian masses. Midlife Health. 2010;1(1):23–5.

Ananya Sinha, Chella Hariharan, Rahul K Chaudhary: preoperative evaluation of ovarian tumors in the rural population-clinical features, grey scale ultrasound, colour doppler, serum ca-125 and alcazar score in predicting malignancy: journal of evolution of medical and dental sciences www.jemds.com/latest-articles.php?at_id=996.

Downloads

Published

2017-02-09

Issue

Section

Original Research Articles